glp 1 drugs and anxiety An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive mental health disorders GLP-1 drugs linked to less

2023 Nov 16;9(1):7

For nearly 7 years and over 20 million consultations on our platform since our founding, weve taken this customer-centric approach with all kinds of sensitive, challenging conditions: breaking down barriers to accessing care, whether through raising awareness, removing stigma, improving access channels, and meaningfully lowering the cost of high-quality care

Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as a primary first-line treatment for type 2 diabetes

Uninsured patients represent one of the fastest-growing populations seeking weight loss medication, driven by rising obesity rates and limited employer-sponsored coverage options